These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Systemic Epstein-Barr Virus-positive T-Cell Lymphoproliferative Disease of Childhood With Good Response to Steroid Therapy. Kim DH; Kim M; Kim Y; Han K; Han E; Lee JW; Chung NG; Cho B J Pediatr Hematol Oncol; 2017 Nov; 39(8):e497-e500. PubMed ID: 28697169 [TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus associated T-cell lymphoproliferative disease misdiagnosed as ulcerative colitis: a case report. Zheng X; Xie J; Zhou X Int J Clin Exp Pathol; 2015; 8(7):8598-602. PubMed ID: 26339440 [TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report. Dutta R; Miao SY; Phan P; Fernandez-Pol S; Shiraz P; Ho D; Mannis GN; Zhang TY J Med Case Rep; 2021 Mar; 15(1):170. PubMed ID: 33773605 [TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-associated lymphoproliferative disorder developed after anti-thymocyte globulin therapy in a patient with bone marrow failure associated with T-cell large granular lymphocytic leukemia. Sumi M; Watanabe M; Sato K; Shimizu I; Ueki T; Akahane D; Ueno M; Ichikawa N; Asano N; Kobayashi H Rinsho Ketsueki; 2011 Nov; 52(11):1782-7. PubMed ID: 22185802 [TBL] [Abstract][Full Text] [Related]
31. Lytic infection of Epstein-Barr virus (EBV) in hemophagocytic syndrome associated with EBV-induced lymphoproliferative disorder. Yamamoto T; Shirakawa A; Kawaguchi M; Masuda A; Nishikawa T; Kobayashi M Ann Hematol; 2004 Feb; 83(2):127-32. PubMed ID: 14530876 [TBL] [Abstract][Full Text] [Related]
32. [Clinicopathologic features of systemic EBV-positive T-cell lymphoproliferative disease of childhood]. Jin Y; Zhou XG; He LJ; Xie JL; Zheng YY; Zhang YN; Zhang SH Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):600-8. PubMed ID: 20079188 [TBL] [Abstract][Full Text] [Related]
33. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease]. Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280 [No Abstract] [Full Text] [Related]
34. Characterization of T-/natural killer cell lymphoproliferative neoplasms associated with systemic, chronic, active Epstein-Barr virus in adults: A report of 5 cases in a Western population. Murga-Zamalloa C; Stone MB; Gutierrez MG; Hippalgaonkar NR; Tariq H; Sadeh M; Mehta A; Khan I; Alkan S; Inamdar KV; Wilcox R; Behdad A Am J Clin Pathol; 2024 Jun; 161(6):586-597. PubMed ID: 38345307 [TBL] [Abstract][Full Text] [Related]
35. Hydroa vacciniforme-like Epstein-Barr virus-associated lymphoproliferative disease: a case report. Zeng Y; Fu L; Jin H; Sun Q; Wang B Pediatr Dermatol; 2012; 29(1):96-100. PubMed ID: 21995788 [TBL] [Abstract][Full Text] [Related]
36. The emergence of CD20-/CD19- tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis. Yamamoto N; Nishimura N; Takeuchi M; Ito T; Yokozaki H; Hirase S; Kubokawa I; Mori T; Yanai T; Hayakawa A; Takeshima Y; Nishio H; Matsuo M; Imadome K; Iijima K Eur J Pediatr; 2014 Dec; 173(12):1615-8. PubMed ID: 24169729 [TBL] [Abstract][Full Text] [Related]
37. Primary Intestinal Epstein-Barr Virus-associated Natural Killer/T-cell Lymphoproliferative Disorder: A Disease Mimicking Inflammatory Bowel Disease. Wang Z; Zhang W; Luo C; Zhu M; Zhen Y; Mu J; Zhang Y; Hu R; Wang Y; Wen Z; Ouyang Q; Xiao S; Zhang H J Crohns Colitis; 2018 Jul; 12(8):896-904. PubMed ID: 29635312 [TBL] [Abstract][Full Text] [Related]